Syntheses and Biological Activities of New Hybrid Molecules Containing Different Heterocyclic Moieties
- 6 September 2013
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 346 (10) , 743-756
Abstract
4‐Aryl‐5‐(pyridin‐3‐yl)‐4H‐1,2,4‐triazole‐3‐(thi)oles 5–7, obtained starting from nicotinic acid hydrazide were converted to the corresponding Mannich bases 12–24 by the reaction with several heterocyclic amines in the presence of formaldehyde. The synthesis of S‐alkylated compounds 8–11 was performed from the reaction of the corresponding triazol‐5‐thioles with various alkyl halides. The condensation of carbo(thio)amides 2–4 with 4‐chlorophenacyl bromide afforded the corresponding 1,3‐thia(oxa)zol‐2(3H)‐ylidene]pyridine‐3‐carbohydrazides 25–27. 1,3‐Thia(oxa)zolidine derivatives 28–30 were obtained from the cyclization reaction between compounds 2–4 and ethyl bromoacetate. All newly synthesized compounds were screened for their antimicrobial, antiurease, and antilipase activities. The biological activity studies revealed that all the compounds screened showed good or moderate antimicrobial, antiurease, and/or antilipase activity.Keywords
This publication has 58 references indexed in Scilit:
- Microwave assisted synthesis of some hybrid molecules derived from norfloxacin and investigation of their biological activitiesEuropean Journal of Medicinal Chemistry, 2013
- Antimicrobial and antiurease activities of newly synthesized morpholine derivatives containing an azole nucleusMedicinal Chemistry Research, 2012
- Synthesis of novel 1,2,4-oxadiazoles and analogues as potential anticancer agentsEuropean Journal of Medicinal Chemistry, 2011
- Synthesis, characterization and biological activity of some new 1,3,4-oxadiazole bearing 2-flouro-4-methoxy phenyl moietyEuropean Journal of Medicinal Chemistry, 2010
- Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activitiesEuropean Journal of Medicinal Chemistry, 2009
- Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analoguesBioorganic & Medicinal Chemistry Letters, 2009
- New potential antibacterials: A synthetic route to N-aryloxazolidinone/3-aryltetrahydroisoquinoline hybridsBioorganic & Medicinal Chemistry Letters, 2006
- Pharmaceutical approaches to the treatment of obesityDrug Discovery Today, 2004
- Kinetics of novel competitive inhibitors of urease enzymes by a focused library of oxadiazoles/thiadiazoles and triazolesBiochemical and Biophysical Research Communications, 2004
- Treatment of Systemic Mycoses With Ketoconazole: In Vitro Susceptibilities of Clinical Isolates of Systemic and Pathogenic Fungi to KetoconazoleThe Journal of Infectious Diseases, 1985